Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCMA-Directed CAR-T Cells in Relapsed/Refractory Multiple Myeloma
NCT07689058Phase 2Recruiting
- Start
- Jun 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of LV20.19 CAR-T in multiple myeloma (MM). Started Jun 2026; status: recruiting.
02
Drugs
LV20.19 CAR-T
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT07689058.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07689058.